100% Bullish: Simvastatin in MS, Communicating Risk
Nov 14, 2014•24 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Originally Aired September 10, 2014: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
For the best experience, listen in Metacast app for iOS or Android